Screener
CapEx at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | Six Months Ended / June 27, 2026 | Six Months Ended / June 28, 2025 |
|---|---|---|
| Net cash provided by operating activities | 220,802 | 376,300 |
| Cash flows relating to investing activities | ||
| Acquisition of businesses and assets, net of cash acquired | (467,254) | — |
| Capital expenditures | (87,013) | (94,622) |
| Purchases of investments and contributions to venture capital investments | (11,805) | (8,090) |
| Proceeds from sale of investments | 11,059 | 2,106 |
| Proceeds from sale of businesses and assets, net | 176,563 | 17,441 |
| Other, net | (1,298) | 347 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's capex?
- Charles River Laboratories (CRL) reported capex of $31.11M in Q2 2026.
- How has Charles River Laboratories's capex changed year-over-year?
- Charles River Laboratories's capex decreased by 11.9% year-over-year, from $35.3M to $31.11M.
- What is the long-term trend for Charles River Laboratories's capex?
- Over 4 years (2021 to 2025), Charles River Laboratories's capex has grown at a -1.1% compound annual growth rate (CAGR), from $228.77M to $219.15M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Charles River Laboratories's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude